Vericel (VCEL) EBT Margin Growth (1y) (2012 - 2026)
Vericel (VCEL) EBT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 1,236.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,236.00 |
| Dec 31, 2025 | -50.00 |
| Sep 30, 2025 | 842.00 |
| Jun 30, 2025 | 820.00 |
| Mar 31, 2025 | -1,392.00 |
| Dec 31, 2024 | 479.00 |
| Sep 30, 2024 | 710.00 |
| Jun 30, 2024 | 11,192.00 |
| Mar 31, 2024 | 1,098.00 |
| Dec 31, 2023 | 912.00 |
| Sep 30, 2023 | 845.00 |
| Jun 30, 2023 | -9,735.00 |
| Mar 31, 2023 | 36.00 |
| Dec 31, 2022 | 372.00 |
| Sep 30, 2022 | -248.00 |
| Jun 30, 2022 | -1,494.00 |
| Mar 31, 2022 | -1,042.00 |
| Dec 31, 2021 | -1,857.00 |
| Sep 30, 2021 | -2,629.00 |
| Jun 30, 2021 | 3,192.00 |